跳至主要内容
临床试验/KCT0006018
KCT0006018招募中未知

An exploratory clinical trial to evaluate the clinical benefit of AUC-based vancomycin TDM in Korean patients with MRSA infection

Kangwon National University Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 0No Limit(—)
性别
All

入选标准

  • ? Patients who have the ability to sign the consent form in accordance with GCP and corresponding laws
  • ? Patients who are 19 years or older
  • ? Patients who were decided to administer vancomycin for 7 days or more due to MRSA infection or within 3 days after initiation of vancomycin dosing
  • ? Patient who understands the contents of the clinical research and provide their written informed consent forms

排除标准

  • ? Patients who co-administered vancomycin, except for the intravenous route. (e.g., per oral)
  • ? Patients with contraindications for vancomycin (e.g., Anaphylaxis due to vancomycin)
  • ? Patients in pregnancy or lactation
  • ? Patients whom the researcher deemed inappropriate for clinical research participation

研究者

相似试验

An exploratory clinical trial for optimizing... | 临床试验